STOCK TITAN

Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Silk Road Medical (Nasdaq: SILK) announced it will report its third quarter 2022 financial results on November 8th, 2022, after market close. A live audio webcast will follow, starting at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can register here. Silk Road Medical, based in Sunnyvale, focuses on reducing stroke risks through its TransCarotid Artery Revascularization (TCAR) procedure.

Positive
  • Upcoming financial results announcement may provide insights into revenue growth or new developments.
  • Management will host an audio webcast, allowing investors to engage directly.
Negative
  • None.

SUNNYVALE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2022 after market close on Tuesday, November 8th, 2022. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should register online using this link. Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the webcast will be available at https://investors.silkroadmed.com.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com 


FAQ

When will Silk Road Medical report its third quarter 2022 earnings?

Silk Road Medical will report its third quarter 2022 financial results on November 8th, 2022.

What time is the webcast for Silk Road Medical's third quarter results?

The audio webcast for Silk Road Medical's third quarter results will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Where can I listen to the Silk Road Medical earnings call?

You can listen to the Silk Road Medical earnings call by registering here.

What does Silk Road Medical focus on?

Silk Road Medical focuses on reducing the risk of stroke through innovative treatments like TransCarotid Artery Revascularization (TCAR).

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

1.12B
38.94M
4.15%
97.46%
7.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SUNNYVALE